Selected Publications

Burchell J, Poulsom R, Hanby A, Whitehouse C, Cooper L, Clausen H, Miles D and Taylor-Papadimitriou J. Ana2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 1999; 9: 1307-1311.

Lu P-J, Sundquist K, Baeckstrom D, Poulsom R, Hanby A, Meier-Ewert S, Jones T, Mitchell M, Pitha-Rowe P, Freemont P and Taylor-Papadimitriou J. A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically upregulated in breast cancer. J. Biol. Chem. 1999; 274: 15633- 15645.

Barnes DM and Miles DW. Response of metastatic breast cancer to trastuzumab? Lancet 2000; 355: 160-161.

CarrBrendel V, Markovic D, Ferrer K, Smith M, Taylor-Papadimitriou J and Cohen EP. Immunity to murine breast cancer cells modified to express MUC1, a human breast cancer antigen, in transgenic mice tolerant to human MUC1. Cancer Res. 2000; 60: 2433-2443.

Dalziel M, Whitehouse C, McFarlane I, Brockhausen I, Gschmeissner S, Schwientek T, Clausen H, Burchell JM and Taylor-Papadimitriou J. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumour-associated epitope on MUC1. J. Biol. Chem. 2001; 276: 11007-11015.